{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T23:06:34Z","timestamp":1786748794342,"version":"build-2736575974"},"reference-count":34,"publisher":"Impact Journals, LLC","issue":"32","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,8,9]]},"DOI":"10.18632\/oncotarget.9420","type":"journal-article","created":{"date-parts":[[2016,5,22]],"date-time":"2016-05-22T07:57:46Z","timestamp":1463903866000},"page":"52436-52441","source":"Crossref","is-referenced-by-count":13,"title":["Intrapericardial bevacizumab safely and effectively treats malignant pericardial effusion in advanced cancer patients"],"prefix":"10.18632","volume":"7","author":[{"given":"Dawei","family":"Chen","sequence":"first","affiliation":[{"name":"Weifang Medical University, Weifang, China"},{"name":"Department of Radiation Oncology, Shandong Cancer Hospital affiliated to Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital affiliated to Shandong University, Jinan, China"},{"name":"Shandong Academy of Medical Sciences, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital affiliated to Shandong University, Jinan, China"},{"name":"Shandong Academy of Medical Sciences, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital affiliated to Shandong University, Jinan, China"},{"name":"Shandong Academy of Medical Sciences, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghuan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital affiliated to Shandong University, Jinan, China"},{"name":"Shandong Academy of Medical Sciences, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Mengyin People's Hospital, Linyi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital affiliated to Shandong University, Jinan, China"},{"name":"Shandong Academy of Medical Sciences, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital affiliated to Shandong University, Jinan, China"},{"name":"Shandong Academy of Medical Sciences, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,5,17]]},"reference":[{"key":"1","first-page":"287","article-title":"Development of implants for sustained release of 5-fluorouracil using low molecular weight biodegradable polymers","volume":"3","author":"Molokhia","year":"2009","journal-title":"Drug Discoveries and Therapeutics"},{"key":"2","first-page":"57","article-title":"Tumors of the heart and pericardium","volume":"24","author":"Cooley","year":"1999","journal-title":"Current Problems in Cardiology"},{"key":"3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000226344","article-title":"Secondary malignant lesions of the heart and pericardium in neoplastic disease","volume":"43","author":"Skhvatsabaja","year":"1986","journal-title":"Oncology"},{"key":"4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/PL00001998","article-title":"Intrapericardial treatment of neoplastic pericardial effusions","volume":"25","author":"Fiorentini","year":"2000","journal-title":"Herz"},{"key":"5","first-page":"238","article-title":"Cardiac tamponade: an unusual lifethreatening complication after transhiatal resection of the esophagus","volume":"6","author":"Schonberger","year":"2007","journal-title":"Interactive Cardiovascular and Thoracic surgery"},{"key":"6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00540-005-0326-0","article-title":"A case of cardiac tamponade following esophageal resection","volume":"19","author":"Tanaka","year":"2005","journal-title":"Journal of Anesthesia"},{"key":"7","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ygyno.2008.04.028","article-title":"Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer","volume":"111","author":"Rose","year":"2008","journal-title":"Gynecologic Oncology"},{"key":"8","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.3892\/or.2013.2349","article-title":"Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer-mediated malignant pleural effusion","volume":"29","author":"Kang","year":"2013","journal-title":"Oncology Reports"},{"key":"9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ygyno.2006.05.018","article-title":"The use of bevacizumab to palliate symptomatic ascites in patients with refractory ovarian carcinoma","volume":"102","author":"Barnes","year":"2006","journal-title":"Gynecologic Oncology"},{"key":"10","first-page":"1313","article-title":"Effective treatment for malignant pleural effusion and ascites with combined therapy of bevacizumab and cisplatin","volume":"36","author":"Chen","year":"2016","journal-title":"Anticancer Research"},{"key":"11","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0002-9343(77)90154-1","article-title":"Carcinomatous involvement of the pleura: an analysis of 96 patients","volume":"63","author":"Sahn","year":"1977","journal-title":"The American Journal of Medicine"},{"key":"12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/0002-9378(74)90021-0","article-title":"Lymphatic drainage of the peritoneal cavity and its significance in ovarian cancer","volume":"119","author":"Knapp","year":"1974","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/thx.21.5.437","article-title":"Metastatic carcinoma of the pleura","volume":"21","author":"Meyer","year":"1966","journal-title":"Thorax"},{"key":"14","first-page":"1663","article-title":"The role of lymphatic obstruction in the formation of ascites in a murine ovarian carcinoma","volume":"32","author":"Hellman","year":"1972","journal-title":"Cancer Research"},{"key":"15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0022-4804(84)90094-5","article-title":"Prevention of carcinomatosis and bloody malignant ascites in the rat by an inhibitor of angiogenesis","volume":"36","author":"Folkman","year":"1984","journal-title":"The Journal of Surgical Research"},{"key":"16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0065-230X(08)60058-5","article-title":"Tumor angiogenesis","volume":"19","author":"Folkman","year":"1974","journal-title":"Advances in Cancer Research"},{"key":"17","first-page":"110","article-title":"Tumor angiogenesis activity in cells grown in tissue culture","volume":"36","author":"Folkman","year":"1976","journal-title":"Cancer Research"},{"key":"18","first-page":"381","article-title":"Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions","volume":"13","author":"Jin","year":"2009","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jnci\/89.2.139","article-title":"Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma","volume":"89","author":"Tominaga","year":"1997","journal-title":"Journal of the National Cancer Institute"},{"key":"20","first-page":"861","article-title":"Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma","volume":"3","author":"Bevilacqua","year":"1997","journal-title":"Clinical Cancer Research"},{"key":"21","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.18632\/oncotarget.6184","article-title":"Greater efficacy of chemotherapy plus bevacizumab compared to chemo- and targeted therapy alone on non-small cell lung cancer patients with brain metastasis","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"22","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1440-1843.2009.01628.x","article-title":"Monoclonal anti-vascular endothelial growth factor antibody reduces fluid volume in an experimental model of inflammatory pleural effusion","volume":"14","author":"Teixeira","year":"2009","journal-title":"Respirology"},{"key":"23","first-page":"2652","article-title":"Significant expression of vascular endothelial growth factor\/vascular permeability factor in mouse ascites tumors","volume":"58","author":"Shibuya","year":"1998","journal-title":"Cancer Research"},{"key":"24","first-page":"5721","article-title":"Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model","volume":"9","author":"Jaffe","year":"2003","journal-title":"Clinical Cancer Research"},{"key":"25","first-page":"445","article-title":"Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases","volume":"16","author":"Fidler","year":"2000","journal-title":"International Journal of Oncology"},{"key":"26","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/10799900050023933","article-title":"VEGF\/Flk-1 interaction, a requirement for malignant ascites recurrence","volume":"20","author":"Mannel","year":"2000","journal-title":"Journal of Interferon and Cytokine Research"},{"key":"27","first-page":"4593","article-title":"Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders","volume":"57","author":"Ferrara","year":"1997","journal-title":"Cancer Research"},{"key":"28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/archsurg.1997.01430290087018","article-title":"Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer","volume":"132","author":"Ellis","year":"1997","journal-title":"Archives of Surgery"},{"key":"29","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.2147\/OTT.S90145","article-title":"Sustained response of malignant pericardial effusion to intrapericardial bevacizumab in an advanced lung cancer patient: a case report and literature review","volume":"8","author":"Yu","year":"2015","journal-title":"OncoTargets and Therapy"},{"key":"30","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1053\/euhj.2002.3328","article-title":"Neoplastic pericardial effusion. Efficacy and safety of intrapericardial treatment with cisplatin","volume":"23","author":"Moll","year":"2002","journal-title":"European Heart Journal"},{"key":"31","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3748\/wjg.v16.i6.740","article-title":"Pericardiocentesis with cisplatin for malignant pericardial effusion and tamponade","volume":"16","author":"Amano","year":"2010","journal-title":"World Journal of Gastroenterology"},{"key":"32","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1200\/JCO.2014.59.4424","article-title":"BEYOND: a randomized, double-blind, placebo-controlled, multicenter, phase III study of first-line carboplatin\/paclitaxel plus bevacizumab or placebo in Chinese patients with advanced or recurrent nonsquamous non-small-cell lung cancer","volume":"33","author":"Hu","year":"2015","journal-title":"Journal of Clinical Oncology"},{"key":"33","first-page":"CD011230","article-title":"Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration","volume":"9","author":"Martin","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"34","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.4103\/0019-509X.154058","article-title":"The efficacy of pemetrexed and bevacizumab intrapleural injection for malignant pleural mesothelioma-mediated malignant pleural effusion","volume":"51","author":"Du","year":"2014","journal-title":"Indian Journal of Cancer"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9420","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T09:32:07Z","timestamp":1589275927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,17]]},"references-count":34,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2016,8,9]]}},"alternative-id":["9420","27203219"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.9420","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,17]]}}}